Press Resease

Antifungal Drug Market - Global Industry Analysis

Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2026

Published Date: 16-Dec-2016 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-534 Status : Published

According to the report, the Antifungal Drug Market accounted for USD 13.14 Billion in 2019 and is expected to reach USD 16.83 Billion by 2026, growing at a CAGR of around 3.6% between 2020 and 2026.

Description

The report covers forecast and analysis for the antifungal drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the antifungal drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the antifungal drug market on a global level.

This report offers comprehensive coverage on global antifungal drug market along with, market trends, drivers, and restraints of the antifungal drug market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the antifungal drug market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

Global Antifungal Drug Market

The study provides a decisive view on the antifungal drug market by segmenting the market based on drug type, therapeutic indication, dosage form, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The drug type market covered under this study includes echinocandins, azoles, ployenes, allylamines and others. The therapeutic indication segmentation includes aspergillosis, dermatophytosis, candidiasis and others. The dosage form segmentation includes powder, ointment, drug, and paste. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into US, UK, Germany, France, Japan, China, India, and Brazil.  

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, Glaxosmithkline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck & Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead.

This report segments the global antifungal drug market as follows:

Global Antifungal Drug Market: Drug Type Analysis

  • Echinocandins                                                       
  • Azoles                                                      
  • Polyenes                                                 
  • Allylamines                                                            
  • Others

Global Antifungal Drug Market: Therapeutic Indication Analysis

  • Aspergillosis                                                          
  • Dermatophytosis                                                
  • Candidiasis                                                              
  • Others

Global Antifungal Drug Market: Dosage Form Analysis

  • Powders                                                 
  • Ointments                                                              
  • Drugs                                                        
  • Pastes

Global Antifungal Drug Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East And Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Antifungal Drug Market, 2016-2026 (USD Billion)
    • 2.2. Antifungal Drug Market: Snapshot
  • Chapter 3. Antifungal Drug Market - Industry Analysis
    • 3.1. Antifungal Drug Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rapid Spread Of Fungal Infection
      • 3.2.2. Pandemicity Of Fungal Infection
    • 3.3. Restraints
      • 3.3.1. High Penetration Of Conventional Drugs
    • 3.4. Opportunity
      • 3.4.1. Covering Untapped Market
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Drug Type
      • 3.6.2. Market attractiveness analysis By Dosage Form
      • 3.6.3. Market attractiveness analysis By Therapeutic Indication
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. Antifungal Drug Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Antifungal Drug Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Drug Type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Antifungal Drug Market -Drug Type Analysis
    • 5.1. Global Antifungal Drug Market overview: By Drug Type type
      • 5.1.1. Global Antifungal Drug Market share, By Drug Type,2019 and 2026
    • 5.2. Echinocandins
      • 5.2.1. Global Antifungal Drug Market by Echinocandins, 2016-2026 (USD Billion)
    • 5.3. Azoles
      • 5.3.1. Global Antifungal Drug Market by Azoles, 2016-2026 (USD Billion)
    • 5.4. Ployenes
      • 5.4.1. Global Antifungal Drug Market by Ployenes, 2016-2026 (USD Billion)
    • 5.5. Allylamines
      • 5.5.1. Global Antifungal Drug Market by Allylamines, 2016-2026 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Antifungal Drug Market by others, 2016-2026 (USD Billion)
  • Chapter 6. Global Antifungal Drug Market -Dosage Form Analysis
    • 6.1. Global Antifungal Drug Market overview: By Dosage Form
      • 6.1.1. Global Antifungal Drug Market share, By Dosage Form, 2019 and 2026
    • 6.2. Powders
      • 6.2.1. Global Antifungal Drug Market By Powders, 2016-2026 (USD Billion)
    • 6.3. Ointments
      • 6.3.1. Global Antifungal Drug Market By Ointments, 2016-2026 (USD Billion)
    • 6.4. Drugs
      • 6.4.1. Global Antifungal Drug Market By Drugs, 2016-2026 (USD Billion)
    • 6.5. Pastes
      • 6.5.1. Global Antifungal Drug Market By Pastes, 2016-2026 (USD Billion)
  • Chapter 7. Global Antifungal Drug Market -Therapeutic Indication Analysis
    • 7.1. Global Antifungal Drug Market overview: By Therapeutic Indication
      • 7.1.1. Global Antifungal Drug Market share, By Therapeutic Indication, 2019 and 2026
    • 7.2. Aspergillosis
      • 7.2.1. Global Antifungal Drug Market by Aspergillosis, 2016-2026 (USD Billion)
    • 7.3. Dermatophytosis
      • 7.3.1. Global Antifungal Drug Market by Dermatophytosis, 2016-2026 (USD Billion)
    • 7.4. Candidiasis
      • 7.4.1. Global Antifungal Drug Market by Candidiasis, 2016-2026 (USD Billion)
    • 7.5. Others
      • 7.5.1. Global Antifungal Drug Market by others, 2016-2026 (USD Billion)
  • Chapter 8. Global Antifungal Drug Market - Regional Analysis
  • 8.1. Global Antifungal Drug Market overview: by Region
    • 8.1.1. Global Antifungal Drug Marketshare, by Region, 2019 and 2026
  • 8.2. North America
    • 8.2.1. North America Antifungal Drug Market, 2016-2026 (USD Billion)
    • 8.2.2. North America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
    • 8.2.3. North America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
    • 8.2.4. North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.2.5. The U.S.
      • 8.2.5.1. The U.S.Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.2.5.2. The U.S.Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.2.5.3. The U.S.Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.2.6.2. Rest of North America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.2.6.3. Rest of North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Antifungal Drug Market, 2016-2026 (USD Billion)
    • 8.3.2. Europe Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
    • 8.3.3. Europe Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
    • 8.3.4. Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.3.5. UK
      • 8.3.5.1. U.K.Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.3.5.2. U.K.Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.3.5.3. U.K. Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.3.6.2. France Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.3.6.3. France Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.3.7. Germany
      • 8.3.7.1. Germany Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.3.7.2. Germany Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.3.7.3. Germany Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of EuropeAntifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.3.8.2. Rest of EuropeAntifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.3.8.3. Rest of Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Antifungal Drug Market, 2016-2026 (USD Billion)
    • 8.4.2. Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
    • 8.4.3. Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
    • 8.4.4. Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.4.5. China
      • 8.4.5.1. China Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.4.5.2. China Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.4.5.3. China Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.4.6. Japan
      • 8.4.6.1. Japan Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.4.6.2. Japan Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.4.6.3. Japan Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.4.7. India
      • 8.4.7.1. India Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.4.7.2. India Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.4.7.3. India Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.4.8.2. Rest of Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.4.8.3. Rest of Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Antifungal Drug Market, 2016-2026 (USD Billion)
    • 8.5.2. Latin America Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
    • 8.5.3. Latin America Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
    • 8.5.4. Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.5.5.2. Brazil Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.5.5.3. Brazil Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
    • 8.5.6. Rest of LatinAmerica
      • 8.5.6.1. Rest of LatinAmerica Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
      • 8.5.6.2. Rest of LatinAmerica Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
      • 8.5.6.3. Rest of Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Antifungal Drug Market, 2016-2026 (USD Billion)
    • 8.6.2. The Middle East and Africa Antifungal Drug Market revenue, By Drug Type,2016-2026 (USD Billion)
    • 8.6.3. The Middle East and Africa Antifungal Drug Market revenue, By Dosage Form, 2016-2026 (USD Billion)
    • 8.6.4. The Middle East and Africa Antifungal Drug Market revenue, By Therapeutic Indication, 2016-2026 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Asperqillus
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Drug Type Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Alternaria
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Drug Type Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Abbott Laboratories
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Drug Type Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Pfizer
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Drug Type Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Glaxosmithkline
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Drug Type Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Bayer Healthcare
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Drug Type Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Novartis
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Drug Type Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Sanofi-Aventis
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Drug Type Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Merck & Co.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Drug Type Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Kramer Laboratories
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Drug Type Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

List of Figures

1. Market research process
2. Market research methodology
3. Global Antifungal Drug Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Antifungal Drug Market attractiveness, By Drug Type type
6. Global Antifungal Drug Market attractiveness, By Dosage Form
7. Global Antifungal Drug Market attractiveness, By Therapeutic Indication
8. Global Antifungal Drug Marketmarket share, By Drug Type, 2019 and 2026
9. Global Antifungal Drug Market by Echinocandins, 2016–2026 (USD Billion)
10. Global Antifungal Drug Market by Azoles,2016–2026 (USD Billion)
11. Global Antifungal Drug Market by Ployenes,2016–2026 (USD Billion)
12. Global Antifungal Drug Market by Allylamines,2016–2026 (USD Billion)
13. Global Antifungal Drug Market by Others,2016–2026 (USD Billion)
14. Global Antifungal Drug Market share, By Dosage Form, 2019 and 2026
15. Global Antifungal Drug Market By Powders, 2016–2026 (USD Billion)
16. Global Antifungal Drug Market By Ointments, 2016–2026 (USD Billion)
17. Global Antifungal Drug Market By Drugs, 2016–2026 (USD Billion)
18. Global Antifungal Drug Market By Pastes, 2016–2026 (USD Billion)
19. Global Antifungal Drug Market share, By Therapeutic Indication, 2019 and 2026
20. Global Antifungal Drug Market by Aspergillosis, 2016–2026 (USD Billion)
21. Global Antifungal Drug Market by Dermatophytosis, 2016–2026 (USD Billion)
22. Global Antifungal Drug Market by Candidiasis, 2016–2026 (USD Billion)
23. Global Antifungal Drug Market by Others, 2016–2026 (USD Billion)
24. Global Antifungal Drug Market share, by Region, 2019and 2026
25. North America Antifungal Drug Market, 2016–2026 (USD Billion)
26. Europe Antifungal Drug Market, 2016–2026 (USD Billion)
27. Asia Pacific Antifungal Drug Market, 2016–2026 (USD Billion)
28. Latin America Antifungal Drug Market, 2016–2026 (USD Billion)
29. The Middle East and Africa Antifungal Drug Market, 2016–2026 (USD Billion)


List of Tables

1. Global Antifungal Drug Market: snapshot
2. Drivers of theAntifungal Drug Market: impact analysis
3. Restraints of theAntifungal Drug Market: impact analysis
4. North America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
5. North America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
6. North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
7. The U.S. Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
8. The U.S. Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
9. The U.S. Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
10. Rest of North America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
11. Rest of North America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
12. Rest of North America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
13. Europe Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
14. Europe Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
15. Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
16. U.K.Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
17. U.K.Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
18. U.K. Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
19. France Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
20. France Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
21. France Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
22. Germany Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
23. Germany Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
24. Germany Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
25. Rest of EuropeAntifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
26. Rest of EuropeAntifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
27. Rest of Europe Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
28. Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
29. Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
30. Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
31. China Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
32. China Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
33. China Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
34. Japan Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
35. Japan Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
36. Japan Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
37. India Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
38. India Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
39. India Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
40. Rest of Asia Pacific Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
41. Rest of Asia Pacific Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
42. Rest of Asia Pacific Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
43. Latin America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
44. Latin America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
45. Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
46. Brazil Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
47. Brazil Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
48. Brazil Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
49. Rest of Latin America Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
50. Rest of Latin America Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
51. Rest of Latin America Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)
52. The Middle East and Africa Antifungal Drug Market revenue, By Drug Type,2016–2026 (USD Billion)
53. The Middle East and Africa Antifungal Drug Market revenue, By Dosage Form, 2016–2026 (USD Billion)
54. The Middle East and Africa Antifungal Drug Market revenue, By Therapeutic Indication, 2016–2026 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Antifungal Drug market. Zion Research has collected and analyzed key data belong to the global Antifungal Drug market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Antifungal Drug across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Antifungal Drug industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Antifungal Drug market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Fungi are a diverse group of microorganisms that have modified themselves to remain alive in a wide array of environments. These environments may vary from the human body to discrete areas of nature. Fungi can produce diverse human infections ranging from superficial skin infections to internal organ invasion in the body. These viable infections usually happen due to decrease in natural human defenses/immune system or due to heavy exposure to the fungus. Selection of   therapies for treating fungal infections based on the type of infection or type of fungus involved in infection. Topical/superficial infections are usually treated with topical agents whereas peripheral infection is treated with systemic therapy.

Globally, antifungal drug market has been accelerated due to continuous rise in percentage of fungal infections specially the ringworm infection. Furthermore, lack of awareness coupled with self-medication is considered as major key factors which are expected to promote the growth of antifungal drug market. Moreover many lifestyle-related factors, such as sedentary lifestyle, eating junk food which may leads to weaken the immune system and thus promote the fungal growth. However, high penetration of conventional drugs is key restraining factor for the growth of anti-fungal drug market. Nonetheless, ongoing research and development in prevention and treatment of fungal infection like to bring growth avenues nearby future.

Based on drug type, the global market of antifungal drug is bifurcated into five types: echinocandins, azoles, ployenes, allylamines and others. Azoles are systemically acting antifungal drug which include fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole. The echinocandins are lipopeptides derived from natural fungal fermentation products. They include anidulafungin, caspofungin and micafungin. Azole derivative was the leading derivatives in term of generating revenue in 2019 and this growth is expected to continue within the forecast period. The growth is attributed due to effective price and fungicidal properties of azole derivatives like ketokonazole, itaconazole etc.

Based on therapeutic indication, the global market of antifungal drug is bifurcated into four types: aspergillosis, dermatophytosis, candidiasis and others. The most commonly encountered fungal infections are those that affect the skin layers. Approximately 1-2% of the world’s population is affected by dermatophytoses (superficial fungal infections of the skin). Seborric dermatisis, ringworm infection, jock itch are the examples of various topical fungal infections.

Based on dosage form, the global market of antifungal drug is bifurcated into four types: powders, ointments, drugs and pastes. Over the counter antifungal drugs like clo-trimoxazole (sulphamethoxazole + trimethoprim) are available in powder, ointment form and can be easily obtained without doctor/physician prescriptions. Whereas, majority of the oral antifungal drugs are prescription based medicines and are available in various dosage forms such as tablets, capsules and suspensions. Powder, ointment is covering approximately more than 55% of antifungal drug market.

Based on geographies, the global market of antifungal drug is bifurcated into five types: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India and Brazil. North America accounted for the largest share of the global antifungal market, followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, antifungal drug market has huge opportunity in the emerging markets of Asia Pacific region due to increasing standard of living, large pool of patient in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of fungal infection, increasing government support and growing upper middle-class population and rise in disposable income level in this region. Understanding the rising episodes of fungal infections in the country, the government employed various measures on its own including public private partnership (PPP). This development is largely responsible for propelling the Indian market of antifungal drug.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, Glaxosmithkline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck & Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social